Jan 21, 2019With approval of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, Abbott is helping more physicians integrate ablation with 3D mapping to advance the treatment of people with atrial fibrillation-
Jan 19, 2019- Data from two recent studies presented at NANS 2019 demonstrate key benefits of BurstDR™ stimulation- Microdosing BurstDR stimulation at lowest effective energy allows patients to manage their pain without the burden of recharging their devices- Additional data further showed switching from other types of SCS therapies to Abbott’s BurstDR stimulation significantly reduced pain and the need for opioid medication
-
Nov 15, 2018New White Paper Shares Research Findings on Perceptions and Awareness of Medical Device Cybersecurity, Need for Collaboration to Address Cybersecurity Challenges
-
Oct 25, 2018NEW ASSAYS EMPOWER CLINICIANS TO MORE QUICKLY MAKE THE RIGHT DIAGNOSIS AT THE POINT-OF-CARE AND PRESCRIBE THE RIGHT TREATMENT
-
Oct 17, 2018PRELIMINARY RESEARCH INDICATES THAT A DIAGNOSTIC TEST CURRENTLY IN DEVELOPMENT, THAT IS DONE AT THE PATIENT'S SIDE IN MINUTES, HAS SIMILAR ACCURACY TO A HIGH-SENSITIVE TROPONIN TEST FOR EARLY RULE OUT OF A HEART ATTACK
-
May 22, 2018- Data presented at EuroPCR indicated excellent clinical outcomes for Portico in a real-world setting to treat common and life-threatening heart valve disease with minimally invasive option- Portico is the first fully resheathable, repositionable and retrievable device – now with a sheathless delivery option – to replace a diseased or damaged aortic heart valve without major surgery- Data are consistent with earlier study results used to support CE Mark
-
Apr 11, 2018- Largest-ever randomized trial to evaluate superiority of light-based, three-dimensional imaging (optical coherence tomography (OCT)) versus X-ray-based angiography in patients with complex coronary artery disease who receive a stent- Trial will assess if stent procedures guided by high-resolution imaging result in larger vessel diameters and improved patient clinical outcomes versus stent procedures that use standard-of-care imaging- Use of OCT imaging may help doctors be more precise in stent implantation
- Mar 6, 2018- First and only pediatric mechanical heart valve developed to include newborns and infants- Life-saving technology - the size of a dime - provides new treatment option to address unmet need- Nearly one in four children with critical heart defects may require surgery or other procedures in their first year of life[1]
-
Oct 11, 2017- A new dataset published in The Lancet: Psychiatry highlights the largest prospective study in DBS for chronic, treatment-resistant depression
- Jan 10, 2017- Innovative solution designed for blood and plasma screening maintains highest levels of accuracy while substantially increasing productivity
- Jan 10, 2017- Next generation of harmonized systems, combined with recently launched AlinIQ professional services, provide a unique solution to help labs and hospital systems achieve measurably better healthcare performance- The Alinity family delivers unprecedented integration in diagnostic testing to help solve the lab's most pressing challenges- New clinical chemistry and immunoassay technologies allow for cost-effective volume growth in a footprint half the size of Abbott's current diagnostic systems[1]- Error-proof design elements help prevent costly mistakes in the lab- Easy-to-use software, common across all Alinity systems, helps labs simplify training and manage strained staffing resources- Scalable system design enables labs to address current and future needs
